UK Medicinal Cannabis Company Grow Pharma to Produce Cannabis-Based Medicinal Products for Patients Facing Possible Disruption In SupplyPosted by On


Innovative UK medicinal cannabis distributor Grow Pharma today announced that they have trialled the first UK extraction of a CBMP in a licensed facility, other than GW Pharmaceuticals, in their efforts to replicate and distribute cannabis-based medicinal products (CBMPs) to patients whose supply may be disrupted due to technicalities relating to Brexit.

“Although it has been announced that a temporary solution has been found and companies are working on a longer term solution which may take months, a post Brexit, sustainable and UK based solution for this problem is needed and we are ready to step up to help,” says Pierre van Weperen, CEO of Grow Pharma. He also mentioned that when prescriptions come in, initial samples will be made available free of charge and the actual cost moving forward will be significantly less than parents are used to paying.

Grow Pharma are already legally importing GMP produced Bedrocan flowers into the UK for distribution to medicinal cannabis patients. Bedrocan strains are used to produce the cannabis oil that around 40 families were collecting from a Dutch pharmacy.

Grow Pharma’s partner, IPS Pharma, will produce the cannabis oils in their state-of-the-art EU GMP certified production facility which is based in Surrey. IPS will also be able to capitalise upon extraction and processing expertise developed over three years of research and…

Original Author Link click here to read complete story..

Innovative UK medicinal cannabis distributor Grow Pharma today announced that they have trialled the first UK extraction of a CBMP in a licensed facility, other than GW Pharmaceuticals, in their efforts to replicate and distribute cannabis-based medicinal products (CBMPs) to patients whose supply may be disrupted due to technicalities relating to Brexit.

“Although it has been announced that a temporary solution has been found and companies are working on a longer term solution which may take months, a post Brexit, sustainable and UK based solution for this problem is needed and we are ready to step up to help,” says Pierre van Weperen, CEO of Grow Pharma. He also mentioned that when prescriptions come in, initial samples will be made available free of charge and the actual cost moving forward will be significantly less than parents are used to paying.

Grow Pharma are already legally importing GMP produced Bedrocan flowers into the UK for distribution to medicinal cannabis patients. Bedrocan strains are used to produce the cannabis oil that around 40 families were collecting from a Dutch pharmacy.

Grow Pharma’s partner, IPS Pharma, will produce the cannabis oils in their state-of-the-art EU GMP certified production facility which is based in Surrey. IPS will also be able to capitalise upon extraction and processing expertise developed over three years of research and…



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.